Johnson & Johnson (JNJ)
International Stocks
Buy
The speaker reviews the company's new product cycle, developments in oncology, and the impact of litigation processes on the stock.
V
Vamil Divan76d* Does not constitute investment advice
Yükleniyor...
Radar Rating
Average
5-dimension analyst performance assessment
Total Analyses
1
Buy
1
Sell
0
Hold
0
Unique Assets
1
Active Days
76+
The speaker reviews the company's new product cycle, developments in oncology, and the impact of litigation processes on the stock.
* Does not constitute investment advice